Relationship between peripheral arterial disease and metabolic syndrome

Angiology

Volumn 60, Issue 5, 2009, Pages 546-553

  Maksimovic, Milos ^a   Vlajinac, Hristina ^a   Radak, Djordje ^a   Marinkovic, Jelena ^a   Jorga, Jagoda ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Cross sectional study; Metabolic syndrome; Peripheral arterial disease

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; URIC ACID;

ADULT; ALCOHOL CONSUMPTION; ARTERY DISEASE; ARTICLE; BLOOD PRESSURE; BODY FAT; BODY MASS; BODY WEIGHT; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GANGRENE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PREVALENCE; PROTEIN BLOOD LEVEL; SCORING SYSTEM; SMOKING; URIC ACID BLOOD LEVEL;

AGED; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; C-REACTIVE PROTEIN; CHOLESTEROL, HDL; CROSS-SECTIONAL STUDIES; EDUCATIONAL STATUS; FEMALE; GANGRENE; HUMANS; LOGISTIC MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; SERBIA; SEVERITY OF ILLNESS INDEX; SMOKING; TRIGLYCERIDES; URIC ACID; WAIST CIRCUMFERENCE;

EID: 68349158334     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/0003319708325445     Document Type: Article

References (26)

1. Greenland P., Abrams J., Aurigemma GP, et al., for the Writing Group III. Prevention Conference V, beyond secondary prevention: identifying the high-risk patient for primary prevention: noninvasive tests of atherosclerosis burden. Circulation. 2000 ;101: e16-e22.
2. Criqui MH, Fonek A., Klauber MR, Barrett-Connor E., Gabriel S. The sensitivity, specificity, and predictive value of traditional clinical evaluation of peripheral arterial disease: results from noninvasive testing in a defined population. Circulation. 1985 ; 71: 515-522.
3. Aronow WS Management of peripheral arterial disease of the lower extremities in elderly patients. J Gerontol. 2004 ; 59A: 172-177.
4. Fowkes FGR Epidemiological research on peripheral vascular disease. J Clin Epidemiol. 2001 ; 54: 863-868.
5. Gorter PM, Olijhoek JK, van der Graaf Y., Algra A., Rabelink TJ, Visseren FLJ The SMART Study Group. Prevalence of the metabolic syndrome in patients with coronary heart disease, cerebrovascular disease, peripheral arterial disease or abdominal aortic aneurysm. Atherosclerosis. 2004 ; 173: 363-369. (Pubitemid 38469808)
6. Olijhoek JK, van der Graaf Y., Banga JD, Algra A., Rabelink TJ, Visseren FLJ The SMART Study Group. The metabolic syndrome is associated with advanced vascular damage in patients with coronary heart disease, stroke, peripheral arterial disease or abdominal aortic aneurysm. Eur Heart J. 2004 ; 25: 342-348. (Pubitemid 38295444)
7. Brevetti G., Schiano V., Sirico G., Giugliano G., Laurenzano E., Chiariello M. Metabolic syndrome in peripheral arterial disease: relationship with severity of peripheral circulatory insufficiency, inflammatory status, and cardiovascular morbidity. J Vasc Surg. 2006 ; 44: 101-107.
8. Qadan LR, Ahmed AA, Safar HA, Al-Bader MA, Ali AA Prevalence of metabolic syndrome in patients with clinically advanced peripheral vascular disease. Angiology. 2008 ; 59: 198-202.
9. World Health Organization. Obesity: Preventing and Managing the Global Epidemic. Geneva: WHO ; 1998.
10. Durnin Jvga, Womersley J. Body fat assessed from total body density and its estimation from skin fold thickness; measurements on 481 men and women aged from 16 to 72 years. Br J Nutr. 1974 ; 32: 77-97.
11. Chobanian AV, Bakris GL, Black HR, et al., and the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, National Heart, Lung, and Blood Institute and National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003 ; 42: 1206-1252.
12. Centers for Disease Control. American Heart Association Workshop on Inflammatory Markers, and Cardiovascular Disease: Application to Clinical and Public Health Practice: Atlanta, March 14-15, 2002. Atlanta, GA: Centers for Disease Control and Prevention ; 2002.
13. Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment panel III). Final report. Circulation. 2002 ; 106: 3143-3421.
14. Wild S., Smith F., Lee A., Fowkes G. Ankle-brachial pressure index and metabolic syndrome are independent predictors of cardiovascular disease mortality in the Edinburgh Artery Study cohort. Circulation. 2004 ; 109: E133 - E134.
15. Lahoz C., Vicente I., Laguna F., Garcia-Iglesias MF, Taboada M., Mostaza JM Metabolic syndrome and asymptomatic peripheral artery disease in subjects over 60 years of age. Diabetes Care. 2006 ; 29: 148-150.
16. Fowkes FGR Epidemiology of Peripheral Arterial Disease. London: Springer Verlag ; 1991.
17. Shuldiner AR, Yang R., Gong DW, Resistinobesity and insulin resistance. The emerging role of the adipocyte as an endocrine organ. N Engl J Med. 2001 ; 345: 1345-1346.
18. Ridker PM, Stampfer MJ, Rifai N. Novel risk factors for systemic atherosclerosis. JAMA. 2001 ; 285: 2481-2485.
19. Shankar A., Li J., Nieto JF, Klein BE, Klein R. Association between C-reactive protein level and peripheral arterial disease among US adults without cardiovascular disease, diabetes, or hypertension. Am Heart J. 2007 ; 154: 495-501.
20. Langlois M., De Bacquer D., Duprez D., De Buyzere M., Delanghe J., Blaton V. Serum uric acid in hypertensive patients with and without peripheral arterial disease. Atherosclerosis. 2003 ; 168: 163-168.
21. Oĝ€™ Hare AM, Bertenthal D., Shlipak MG, Sen S., Chren MM Impact of renal insufficiency on mortality in advanced lower extremity peripheral arterial disease. J Am Soc Nephrol. 2005 ; 16: 514-519.
22. Oĝ€™Hare AM, Rodriguez D., Bacchetti P. Low ankle-brachial index associated with rise in creatinine level over time: results from the atherosclerosis risk in communities study. Arch Intern Med. 2005 ; 165: 1481-1485.
23. Daskalopoulou SS, Pathmarajah M., Kakkos SK, et al. Association between ankle-brachial index and risk factor profile in patients newly diagnosed with intermittent claudication. Circ J. 2008 ; 72: 441-448.
24. Rosvall M., Östergren PO, Hedblad B., Isacasson SO, Janzon L., Berglund G. Socioeconomic differences in the progression of carotid atherosclerosis in middle-aged men and women with subclinical atherosclerosis in Sweden. Soc Sci Med. 2006 ; 62: 1785-1798.
25. Schillinger M., Exner M., Mlekusch W., et al. Statin therapy improves cardiovascular outcome of patients with peripheral artery disease. Eur Heart J. 2004 ; 25: 742-748.
26. Daskalopoulou SS, Daskalopoulos ME, Liapis CD, Mikhailidis DP Peripheral arterial disease: a missed opportunity to administer statins so as to reduce cardiac morbidity and mortality. Curr Med Chem. 2005 ; 12: 433-452.